SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation

NYSE:SEM • US81619Q1058

Current stock price

16.29 USD
0 (0%)
At close:
16.29 USD
0 (0%)
After Hours:

This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SEM Profitability Analysis

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • In the past year SEM had a positive cash flow from operations.
  • Each year in the past 5 years SEM has been profitable.
  • SEM had a positive operating cash flow in each of the past 5 years.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of SEM (2.44%) is comparable to the rest of the industry.
  • SEM has a better Return On Equity (8.38%) than 64.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.27%, SEM is in line with its industry, outperforming 57.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SEM is below the industry average of 8.85%.
  • The 3 year average ROIC (4.28%) for SEM is below the current ROIC(5.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROIC 5.27%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SEM has a Profit Margin of 2.62%. This is in the better half of the industry: SEM outperforms 64.00% of its industry peers.
  • In the last couple of years the Profit Margin of SEM has declined.
  • SEM's Operating Margin of 6.17% is fine compared to the rest of the industry. SEM outperforms 69.00% of its industry peers.
  • In the last couple of years the Operating Margin of SEM has declined.
  • SEM has a worse Gross Margin (11.54%) than 71.00% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SEM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SEM is destroying value.
  • SEM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SEM has been reduced compared to 5 years ago.
  • The debt/assets ratio for SEM is higher compared to a year ago.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.62. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • SEM has a Altman-Z score (1.62) which is in line with its industry peers.
  • The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
  • SEM has a Debt to FCF ratio of 15.74. This is in the lower half of the industry: SEM underperforms 62.00% of its industry peers.
  • SEM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • SEM's Debt to Equity ratio of 1.07 is on the low side compared to the rest of the industry. SEM is outperformed by 61.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Altman-Z 1.62
ROIC/WACC0.62
WACC8.52%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • SEM's Current ratio of 1.04 is on the low side compared to the rest of the industry. SEM is outperformed by 69.00% of its industry peers.
  • SEM has a Quick Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • SEM has a Quick ratio of 1.04. This is in the lower half of the industry: SEM underperforms 61.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SEM Growth Analysis

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • The Earnings Per Share has been decreasing by -9.36% on average over the past years.
  • Looking at the last year, SEM shows a small growth in Revenue. The Revenue has grown by 5.12% in the last year.
  • SEM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.29% yearly.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%

3.2 Future

  • SEM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.12% yearly.
  • Based on estimates for the next years, SEM will show a small growth in Revenue. The Revenue will grow by 4.75% on average per year.
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. SEM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.17, which indicates a correct valuation of SEM.
  • Based on the Price/Earnings ratio, SEM is valued cheaper than 83.00% of the companies in the same industry.
  • SEM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.88.
  • A Price/Forward Earnings ratio of 12.48 indicates a correct valuation of SEM.
  • Based on the Price/Forward Earnings ratio, SEM is valued cheaper than 82.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, SEM is valued a bit cheaper.
Industry RankSector Rank
PE 14.17
Fwd PE 12.48
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SEM is valued a bit cheaper than the industry average as 79.00% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, SEM is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.23
EV/EBITDA 8.02
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • SEM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.05
PEG (5Y)N/A
EPS Next 2Y11.19%
EPS Next 3Y8.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SEM Dividend Analysis

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.54%.
  • Compared to an average industry Dividend Yield of 0.50, SEM pays a better dividend. On top of this SEM pays more dividend than 88.00% of the companies listed in the same industry.
  • SEM's Dividend Yield is comparable with the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

  • SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 21.99% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP21.99%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SEM Fundamentals: All Metrics, Ratios and Statistics

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (3/27/2026, 8:04:00 PM)

After market: 16.29 0 (0%)

16.29

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.51%
Inst Owner Change-3.76%
Ins Owners11.15%
Ins Owner Change0.41%
Market Cap2.02B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts77.78
Price Target17.88 (9.76%)
Short Float %2.92%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-3.49%
PT rev (3m)-3.49%
EPS NQ rev (1m)5.09%
EPS NQ rev (3m)5.09%
EPS NY rev (1m)-1.4%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 14.17
Fwd PE 12.48
P/S 0.37
P/FCF 17.23
P/OCF 5.83
P/B 1.18
P/tB N/A
EV/EBITDA 8.02
EPS(TTM)1.15
EY7.06%
EPS(NY)1.31
Fwd EY8.01%
FCF(TTM)0.95
FCFY5.8%
OCF(TTM)2.79
OCFY17.15%
SpS43.97
BVpS13.75
TBVpS-6.1
PEG (NY)1.05
PEG (5Y)N/A
Graham Number18.86
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 8.38%
ROCE 6.91%
ROIC 5.27%
ROICexc 5.3%
ROICexgc 10.74%
OM 6.17%
PM (TTM) 2.62%
GM 11.54%
FCFM 2.15%
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 15.74
Debt/EBITDA 3.82
Cap/Depr 163.38%
Cap/Sales 4.2%
Interest Coverage 2.79
Cash Conversion 72.71%
Profit Quality 82.03%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 1.62
F-Score5
WACC8.52%
ROIC/WACC0.62
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y13.52%
EPS Next 2Y11.19%
EPS Next 3Y8.12%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year43.55%
EBIT Next 3Y18.69%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%

SELECT MEDICAL HOLDINGS CORP / SEM Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 5 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 14.17 and the Price/Book (PB) ratio is 1.18.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 2 / 10.